News blog

Updates from Europe PMC, a global database of life sciences literature

Europe PMC team

 | 20 November 2009

 | 1 MIN READ

Open Access uptake prompts 9% price reduction for The EMBO Journal and EMBO Reports


Nature Publishing Group (NPG) and the European Molecular Biology Organization (EMBO) have announced that the prices for site licence access to The EMBO Journal and EMBO reports will be reduced by 9% in 2010, reflecting the increased publication of Open Access content in 2008.

Only last month (October 2009) the Wellcome Trust called for greater transparency among publishers to counter the argument that access fees are being paid twice – once through subscriptions and again through publication fees.

This decision by EMBO/NPG to reduce subscription is clearly a step in the right direction, though in the interests of transparency it would be useful if publishers – as a first step – disclosed what proportion of their content was routed through the author-pays model.

Post a comment


I agree to the limited use of my personal data as described in the Europe PMC advanced user services privacy policy.

Creative Commons Licence
This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.

Subscribe to the Europe PMC News blog to receive the latest updates

This website requires cookies, and the limited processing of your personal data in order to function. By using the site you are agreeing to this as outlined in our privacy notice and cookie policy.

Partnerships & funding

Europe PMC is a service of the Europe PMC Funders' Group, in partnership with EMBL’s European Bioinformatics Institute (EMBL-EBI); and in cooperation with the National Center for Biotechnology Information (NCBI) at the U.S. National Library of Medicine (NCBI/NLM) . It includes content provided to the PubMed Central (NLM/PMC) archive by participating publishers.